Keyphrases
Economic Impact
100%
Odds Ratio
100%
Confidence Interval
100%
Clinical Impact
100%
Enterobacteriaceae
100%
Bacteremia
100%
Extended-spectrum-lactamase
100%
Appropriate Therapy
66%
Length of Stay
66%
ESBL Production
66%
Chronic Disease Management
50%
Shekel
33%
Hospital Costs
33%
Israeli
16%
Group by
16%
Between-group
16%
Significant Predictors
16%
High Cost
16%
Mortality Prediction
16%
Multivariable
16%
Healthcare Facilities
16%
Health Care Costs
16%
Infection-related Mortality
16%
Proteus
16%
Klebsiella
16%
Severe Adverse Events
16%
ESBL-E. Coli
16%
ESBL Producers
16%
Enterobacteriaceae Bacteraemia
16%
Facility Costs
16%
Medicine and Dentistry
Odds Ratio
100%
Bacteremia
100%
Penicillinase
100%
Enterobacteriaceae
100%
Extended Spectrum Beta Lactamase
83%
Health Care Cost
50%
Infection
50%
Hospital Cost
33%
Adverse Outcome
16%
Proteus
16%
Klebsiella
16%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
16%
Nursing and Health Professions
Confidence Interval
100%
Odds Ratio
100%
Extended Spectrum Beta Lactamase
100%
Penicillinase
100%
Bacteremia
100%
Length of Stay
66%
Infection
50%
Hospital Cost
33%
Adverse Outcome
16%
Pharmacology, Toxicology and Pharmaceutical Science
Bacteremia
100%
Enterobacteriaceae
100%
Extended Spectrum Beta Lactamase
100%
Penicillinase
100%
Infection
60%
Adverse Outcome
20%
Proteus
20%
Klebsiella
20%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
20%